Minghong Zhong | CEO
GeneLancet Biosciences, Inc.

Dr. Zhong has worked in the drug discovery industry for over 25 years. He is the inventor of multiple patents.  Dr. Zhong is the scientific founder and CEO of GeneLancet, a gene editing company developing precise next-generation gene editing. Prior to GeneLancet, He was a principal scientist at Janssen pharmaceuticals (Johnson & Johnson). His expertise includes both medicinal chemistry and nucleic acids therapeutics. Dr. Zhong is also an adjunct professor (Translational Medicine) at Baruch S. Blumberg Institute. He received his doctoral degree from Brigham Young University and completed his postdoctoral research at Yale University.